InvestorsHub on MSN

Novocure shares slide after phase 3 glioblastoma study falls short of survival goal

Novocure (NASDAQ:NVCR) shares dropped 10% after the company reported that its Phase 3 TRIDENT trial failed to achieve its ...

Novocure's Late-Stage Trial For Tumor Treatment Misses Primary Endpoint

Novocure said a late-stage trial evaluating the earlier initiation of treatment for newly diagnosed glioblastoma didn't demonstrate a statistically significant improvement in overall survival. This ...

Abivax Announces Landmark Phase 3 ABTECT Maintenance Trial Results Evaluating Obefazimod in Moderately to Severely Active Ulcerative Colitis

Abivax Announces Landmark Phase 3 ABTECT Maintenance Trial Results Evaluating Obefazimod in Moderately to Severely Active Ulcerative Colitis At Week 44, both the 25 mg and 50 mg once-daily obefazimod ...
Medical Xpress

Adding tucatinib to first-line maintenance therapy delays disease progression in HER2-positive metastatic breast cancer

Adding tucatinib (Tukysa) to first-line maintenance therapy with trastuzumab (Herceptin) and pertuzumab (Perjeta) delayed disease progression in patients with HER2-positive metastatic breast cancer, ...
Oil

ADNOC completes Phase 1 predictive maintenance project

Abu Dhabi National Oil Co. (ADNOC) has completed the first phase of its large-scale multi-year predictive maintenance project to maximize asset efficiency and integrity across its upstream and ...